Latest news
{{'2026-05-06T05:31:16Z' | dateFormatFilter}}
Novo Nordisk's adjusted operating profit reached DKK 32,858 million in Q1 2026
{{'2026-04-29T21:04:30Z' | dateFormatFilter}}
Novo Nordisk A/S: Denecimig (Mim8) significantly reduced annualised bleeding rate in people with haemophilia A, regardless of inhibitor status, in phase 3 data published in NEJM
{{'2026-04-28T12:00:00Z' | dateFormatFilter}}
Novo Nordisk to present new data on Wegovy®, women with obesity and next-generation weight loss treatments at European Congress on Obesity
Stay informed
Stay informed
Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.
